A No-Nonsense Look at Canopy Growth Since Its IPO

What does it really cost to run Canopy Growth Corp. (TSX:WEED)(NYSE:CGC)?

| More on:

Even if you aren’t a big investor, chances are you’re still aware that the marijuana industry has been the hottest thing since the internet on the stock market.

For the last two or three years, investors have gained (and lost) a lot betting on these stocks, with Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) emerging as one of the top players in this young industry.

Yet even as stocks go up and down, there is still a lot of opportunity to grow in the future. Wall Street estimates that worldwide, cannabis sales could be worth up to US$75 billion a decade from now.

Millennials love marijuana

Part of the reason stocks like Canopy have done so well is that a new wave of investors have entered the market. In fact, Canopy is one of the most popular marijuana stocks held by millennials, based on the 20 most widely held stocks on Robinhood.

To give you an idea of how crazy this is, that means more people own Canopy than other stocks like Facebook or Amazon.

What millennials like is two-fold: its powerhouse of production and global expansion. While the company tends to keep its exact numbers close to its chest, Canopy has been acquiring and expanding at a rapid pace, setting itself up so that estimates are the company can produce well over 500,000 kilograms of marijuana per year.

It’s been no secret that the company has also looked to the United States to further its expansion. Canopy has been acquiring licenses to produce hemp across the country, creating partnerships along the way to set themselves up for when marijuana is likely legalized south of the border.

But beyond the U.S., Canopy has a presence in about 16 countries as of writing, meaning it’s not just banking on North America to make a buck. As I’ve mentioned, there is a huge global opportunity in the works, and Canopy wants a piece of the action.

Whether it’s through medical marijuana, hemp-based products, edibles, makeup, you name it, Canopy is taking over the marijuana market in pretty much any way that exists.

So why has the stock been dropping?

A fine balance

Since its initial public offering (IPO) Canopy has skyrocketed from $0.75 per share in July, 2010 to around $70 per share last summer before coming down after legalization.

It then rebounded in the new year and almost reached all-highs before slumping again to where it trades now at $46.61 per share. But still, if we’re to look at where it all began, that’s an increase of 6,115%!

The slump comes down to the quarterly reports. Across the board, marijuana stocks have been reporting losses, and yet still spending shareholder and partnership dollars to expand its cannabis empire.

Things recently came to a head for Canopy, where after reporting a loss of $323.4 million, founder and CEO Bruce Linton was fired.

Basically, shareholders have to decide if they’re willing to wait for U.S. legalization, ramped up production, and the slew of other projects the company has in store. That’s because this company is looking at that decade-ahead number, and not the numbers hitting the earnings report right now.

Those projects cost money, but those costs only come once. Once you take those costs out, things look a bit different.

So let’s look at Canopy’s bottom line. In its most recent quarterly report ending Mar. 31, 2019, Canopy reported $68.9 million in gross recreational sales, $13.4 million in medical sales, and net revenue of $94.1 million for the quarter.

Its gross profit was $14.97 million for the quarter, which led to a gross margin of 16%, down from 34% the same time last year, and 22% in Q3.

Much of this loss came down to one-time costs, according to Canopy, including $24 million operating expenses for facilities that either aren’t cultivating, not yet harvesting, or under-utilized; a weather event; and other “one-time activities” that it doesn’t foresee affecting future operations.

However, it does foresee future costs related to ramping up production during its “start-up phase.”

So if we cut out those one-time costs, we can get to what investors should really be looking at. With gross profit at $14.97 million, investors should just look at operating expenses of $253.5 million.

So if we take out all those one-time costs, that means the company’s total loss for the quarter was $238.5 million. While it’s still high, it’s about $100 million less than the $323.4 million shown on the quarterly report.

Should you invest $1,000 in TD Bank right now?

Before you buy stock in TD Bank, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and TD Bank wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to its CEO, Mark Zuckerberg, is a member of The Motley Fool's board of directors. Fool contributor Amy Legate-Wolfe owns shares of Canopy Growth. David Gardner owns shares of Amazon and Facebook. Tom Gardner owns shares of Facebook. The Motley Fool owns shares of Amazon and Facebook. Facebook is a recommendation of Stock Advisor Canada.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »